• Something wrong with this record ?

Requirements for design and function of blood pressure measuring devices used for the management of hypertension: Consensus Statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability and STRIDE BP

GS. Stergiou, G. Parati, A. Kollias, AE. Schutte, K. Asayama, R. Asmar, G. Bilo, A. de la Sierra, E. Dolan, J. Filipovsky, G. Head, K. Kario, KG. Kyriakoulis, G. Mancia, E. Manios, A. Menti, RJ. McManus, AS. Mihailidou, P. Muntner, T. Niiranen,...

. 2023 ; 41 (12) : 2088-2094. [pub] 20230609

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

OBJECTIVE: To develop scientific consensus recommendations for the optimal design and functions of different types of blood pressure (BP) measuring devices used in clinical practice for the detection, management, and long-term follow-up of hypertension. METHODS: A scientific consensus meeting was performed by the European Society of Hypertension (ESH) Working Group on BP Monitoring and Cardiovascular Variability and STRIDE BP (Science and Technology for Regional Innovation and Development in Europe) during the 2022 Scientific Meeting of the ESH in Athens, Greece. Manufacturers were also invited to provide their feedback on BP device design and development. Thirty-one international experts in clinical hypertension and BP monitoring contributed to the development of consensus recommendations on the optimal design of BP devices. STATEMENT: International consensus was reached on the requirements for the design and features of five types of BP monitors, including office (or clinic) BP monitors, ambulatory BP monitors, home BP monitors, home BP telemonitors, and kiosk BP monitors for public spaces. For each device type "essential" requirements (must have), and "optional" ones (may have) are presented, as well as additional comments on the optimal device design and features. CONCLUSIONS: These consensus recommendations aim at providing manufacturers of BP devices with the requirements that are considered mandatory, or optional, by clinical experts involved in the detection and management of hypertension. They are also directed to administrative healthcare personnel involved in the provision and purchase of BP devices so that they can recommend the most appropriate ones.

2nd Department of Internal Medicine Medical Faculty of Charles University and University Hospital Pilsen Czech Republic

Cardiology Ubi Cittadella Town Hospital Cittadella Italy

Cardiovascular and Hormonal Research Laboratory Department of Cardiology and Kolling Institute Royal North Shore Hospital Macquarie University Sydney Australia

Cardiovascular Prevention and Research Unit Department of Pathophysiology Medical School National and Kapodistrian University of Athens Athens Greece

Clinical Research Unit Italian Institute of Telemedicine Varese Italy

Columbia Hypertension Center and Lab Department of Medicine Columbia University Irving Medical Center New York New York USA

Department of Clinical Therapeutics National and Kapodistrian University of Athens School of Medicine Athens Greece

Department of Hygiene and Public Health Teikyo University School of Medicine Tokyo Japan

Department of Internal Medicine Hospital Mutua Terrassa University of Barcelona Catalonia Spain

Department of Medicine and Surgery University of Milano Bicocca Milan Italy

Department of Women and Children's Health School of Life Course Sciences FoLSM Kings College London UK

Diagnosis and Therapeutic Center Hotel Dieu Hospital Paris France

Division of Cardiovascular Medicine Department of Medicine Jichi Medical University School of Medicine Tochigi Japan

Foundation Medical Research Institutes Geneva Switzerland

Hypertension Center STRIDE 7 National and Kapodistrian University of Athens School of Medicine 3rd Department of Medicine Sotiria Hospital Athens Greece

Istituto Auxologico Italiano IRCCS Department of Cardiology San Luca Hospital Milan Italy

Menzies Institute for Medical Research University of Tasmania Hobart Australia

National Institute for Health and Welfare and Department of Medicine University of Turku and Turku University Hospital Turku Finland

Neuropharmacology Laboratory Baker Heart and Diabetes Institute Monash University Melbourne Australia

Nuffield Department of Primary Care Health Sciences University of Oxford Oxford UK

School of Population Health University of New South Wales The George Institute for Global Health Sydney Australia

School of Public Health University of Alabama at Birmingham Birmingham Alabama USA

Stroke and Hypertension Unit Connolly Hospital Dublin Ireland

Studium Patavinum Department of Medicine University of Padova Padua Italy

The Conway Institute University College Dublin Ireland

The Shanghai Institute of Hypertension Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China

University of Milano Bicocca Milan Italy

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000550
003      
CZ-PrNML
005      
20240213093242.0
007      
ta
008      
240109s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1097/HJH.0000000000003482 $2 doi
035    __
$a (PubMed)37303225
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Stergiou, George S $u Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
245    10
$a Requirements for design and function of blood pressure measuring devices used for the management of hypertension: Consensus Statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability and STRIDE BP / $c GS. Stergiou, G. Parati, A. Kollias, AE. Schutte, K. Asayama, R. Asmar, G. Bilo, A. de la Sierra, E. Dolan, J. Filipovsky, G. Head, K. Kario, KG. Kyriakoulis, G. Mancia, E. Manios, A. Menti, RJ. McManus, AS. Mihailidou, P. Muntner, T. Niiranen, T. Ohkubo, S. Omboni, A. Protogerou, F. Saladini, J. Sharman, A. Shennan, D. Shimbo, J. Topouchian, J. Wang, E. O'Brien, P. Palatini
520    9_
$a OBJECTIVE: To develop scientific consensus recommendations for the optimal design and functions of different types of blood pressure (BP) measuring devices used in clinical practice for the detection, management, and long-term follow-up of hypertension. METHODS: A scientific consensus meeting was performed by the European Society of Hypertension (ESH) Working Group on BP Monitoring and Cardiovascular Variability and STRIDE BP (Science and Technology for Regional Innovation and Development in Europe) during the 2022 Scientific Meeting of the ESH in Athens, Greece. Manufacturers were also invited to provide their feedback on BP device design and development. Thirty-one international experts in clinical hypertension and BP monitoring contributed to the development of consensus recommendations on the optimal design of BP devices. STATEMENT: International consensus was reached on the requirements for the design and features of five types of BP monitors, including office (or clinic) BP monitors, ambulatory BP monitors, home BP monitors, home BP telemonitors, and kiosk BP monitors for public spaces. For each device type "essential" requirements (must have), and "optional" ones (may have) are presented, as well as additional comments on the optimal device design and features. CONCLUSIONS: These consensus recommendations aim at providing manufacturers of BP devices with the requirements that are considered mandatory, or optional, by clinical experts involved in the detection and management of hypertension. They are also directed to administrative healthcare personnel involved in the provision and purchase of BP devices so that they can recommend the most appropriate ones.
650    _2
$a lidé $7 D006801
650    _2
$a krevní tlak $7 D001794
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    12
$a měření krevního tlaku $7 D001795
650    12
$a hypertenze $x diagnóza $x terapie $7 D006973
650    _2
$a sfygmomanometry $7 D019722
650    _2
$a ambulantní monitorování krevního tlaku $7 D018660
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Parati, Gianfranco $u Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; Istituto Auxologico Italiano, IRCCS, Department of Cardiology, San Luca Hospital, Milan, Italy
700    1_
$a Kollias, Anastasios $u Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
700    1_
$a Schutte, Aletta E $u School of Population Health, University of New South Wales, The George Institute for Global Health, Sydney, Australia
700    1_
$a Asayama, Kei $u Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan
700    1_
$a Asmar, Roland $u Foundation-Medical Research Institutes, Geneva, Switzerland
700    1_
$a Bilo, Grzegorz $u Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; Istituto Auxologico Italiano, IRCCS, Department of Cardiology, San Luca Hospital, Milan, Italy
700    1_
$a de la Sierra, Alejandro $u Department of Internal Medicine, Hospital Mutua Terrassa, University of Barcelona, Catalonia, Spain
700    1_
$a Dolan, Eamon $u Stroke and Hypertension Unit, Connolly Hospital, Dublin, Ireland
700    1_
$a Filipovsky, Jan $u 2nd Department of Internal Medicine, Medical Faculty of Charles University & University Hospital, Pilsen, Czech Republic
700    1_
$a Head, Geoffrey $u Neuropharmacology Laboratory, Baker Heart and Diabetes Institute, Monash University, Melbourne, Australia
700    1_
$a Kario, Kazuomi $u Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
700    1_
$a Kyriakoulis, Konstantinos G $u Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
700    1_
$a Mancia, Giuseppe $u University of Milano-Bicocca, Milan, Italy
700    1_
$a Manios, Efstathios $u Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
700    1_
$a Menti, Ariadni $u Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
700    1_
$a McManus, Richard J $u Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
700    1_
$a Mihailidou, Anastasia S $u Cardiovascular & Hormonal Research Laboratory, Department of Cardiology and Kolling Institute, Royal North Shore Hospital, Macquarie University, Sydney, Australia
700    1_
$a Muntner, Paul $u School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA
700    1_
$a Niiranen, Teemu $u National Institute for Health and Welfare, and Department of Medicine, University of Turku and Turku University Hospital, Turku, Finland
700    1_
$a Ohkubo, Takayoshi $u Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan
700    1_
$a Omboni, Stefano $u Clinical Research Unit, Italian Institute of Telemedicine, Varese, Italy
700    1_
$a Protogerou, Athanasios $u Cardiovascular Prevention and Research Unit, Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
700    1_
$a Saladini, Francesca $u Cardiology Ubi, Cittadella Town Hospital, Cittadella, Italy
700    1_
$a Sharman, James $u Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
700    1_
$a Shennan, Andrew $u Department of Women and Children's Health, School of Life Course Sciences, FoLSM, Kings College London, UK
700    1_
$a Shimbo, Daichi $u Columbia Hypertension Center and Lab, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA
700    1_
$a Topouchian, Jirar $u Diagnosis and Therapeutic Center, Hotel Dieu Hospital, Paris, France
700    1_
$a Wang, Jiguang $u The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
700    1_
$a O'Brien, Eoin $u The Conway Institute, University College Dublin, Ireland
700    1_
$a Palatini, Paolo $u Studium Patavinum, Department of Medicine, University of Padova, Padua, Italy
773    0_
$w MED00002723 $t Journal of hypertension $x 1473-5598 $g Roč. 41, č. 12 (2023), s. 2088-2094
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37303225 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093239 $b ABA008
999    __
$a ok $b bmc $g 2049295 $s 1210244
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 41 $c 12 $d 2088-2094 $e 20230609 $i 1473-5598 $m Journal of hypertension $n J Hypertens $x MED00002723
LZP    __
$a Pubmed-20240109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...